NNMT and obesity due to melanocortin 4 receptor deficiency: Accumulating evidence shows that NNMT regulates histone methylation, polyamine flux, and NAD+-dependent SIRT1 signaling, making it a novel target for treating obesity and type 2 diabetes [47].